OR WAIT null SECS
March 30, 2023
Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.
March 21, 2023
Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.
February 06, 2023
The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.
December 01, 2022
Catalent has completed the expansion of its clinical supply facility located in Shanghai, China.
November 22, 2022
The $286 million investment ability is designed to elevate MillioporeSigma’s ability to conduct biosafety testing and analytical development services.
November 21, 2022
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 11, 2022
The new Massachusetts facility will strengthen Cytiva’s cell culture services.
October 26, 2022
Cambrex has expanded its stability storage business, Q1 Scientific, in Ireland and Belgium.
September 19, 2022
Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.
September 02, 2022
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.